These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 8726713)

  • 1. Treatment of pyoderma gangrenosum with methotrexate.
    Teitel AD
    Cutis; 1996 May; 57(5):326-8. PubMed ID: 8726713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
    Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
    Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic pyoderma gangrenosum: successful resolution with infliximab therapy and pro-inflammatory cytokines assessment.
    Del Giacco SR; Firinu D; Lorrai MM; Serusi L; Meleddu R; Barca MP; Peralta M; Manconi PE
    Acta Derm Venereol; 2012 Jul; 92(4):439-40. PubMed ID: 22392509
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of idiopathic pyoderma gangrenosum with infliximab: induction dosing regimen or on-demand therapy?
    Adişen E; Oztaş M; Gürer MA
    Dermatology; 2008; 216(2):163-5. PubMed ID: 18216480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pyoderma gangrenosum in an infant: Case report].
    Medeiros CC; Colombari ML; Nassif PW; Gurgel AC; Nassif AE
    Dermatol Online J; 2012 Jul; 18(7):6. PubMed ID: 22863628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents.
    Duchini G; Itin P; Arnold A
    Adv Skin Wound Care; 2011 May; 24(5):217-20. PubMed ID: 21505282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image Gallery: Pyoderma gangrenosum of the penis.
    Gisondi P; Pizzolato M; Galvan A; Girolomoni G
    Br J Dermatol; 2018 Jan; 178(1):e62. PubMed ID: 29357609
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
    Carp JM; Onuma E; Das K; Gottlieb AB
    Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyoderma gangrenosum in an infant: A case report and review of the literature.
    Crouse L; McShane D; Morrell DS; Wu EY
    Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab.
    Swale VJ; Saha M; Kapur N; Hoffbrand AV; Rustin MH
    Clin Exp Dermatol; 2005 Mar; 30(2):134-6. PubMed ID: 15725238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory pyoderma gangrenosum treated with infliximab in an infant.
    Campos-Muñoz L; Conde-Taboada A; Aleo E; Toledano E; López-Bran E
    Clin Exp Dermatol; 2014 Apr; 39(3):336-9. PubMed ID: 24635074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophilic dermatosis resembling pyoderma gangrenosum in a dog with polyarthritis.
    Bardagí M; Lloret A; Fondati A; Ferrer L
    J Small Anim Pract; 2007 Apr; 48(4):229-32. PubMed ID: 17381769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
    Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
    Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].
    Nybaek H; Jemec GB
    Ugeskr Laeger; 2005 Aug; 167(32):2920-1. PubMed ID: 16109221
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyoderma gangrenosum and tumor necrosis factor α agents.
    Rallis E; Koumantaki-Mathioudaki E; Tsiatoura A; Stavropoulos P; Katsambas A
    Cutis; 2013 Oct; 92(4):E1-2. PubMed ID: 24195097
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pyoderma gangrenosum: report of 11 cases].
    López de Maturana D; Amaro P; Aranibar L; Segovia L
    Rev Med Chil; 2001 Sep; 129(9):1044-50. PubMed ID: 11725468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulcerative Pyoderma Gangrenosum and Leukocytoclastic Vasculitis in a Hypothyroid Woman: A Case Report.
    Agarwal US; Agarwal P; Prakash C; Sharma P
    Wounds; 2017 Jun; 29(6):E43-E47. PubMed ID: 28682293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of successful treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis, and review of the literature.
    Androutsakos T; Stamopoulos P; Aroni K; Hatzis G
    BMC Gastroenterol; 2015 Oct; 15():149. PubMed ID: 26502871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.